chr13:32954278:AACA>TT Detail (hg19) (BRCA2)

Go to:

Summary
Information
Links
Disease area statistics
MGeND
ClinVar
CIViC
DisGeNET
Annotation
Genome browser

Information

Genome

Assembly	Position
hg19	chr13:32,954,278-32,954,281
hg38	chr13:32,380,141-32,380,144 View the variant detail on this assembly version.

HGVS

BRCA2

Type	Transcript	Protein
RefSeq	NM_000059.3:c.9252_9255delinsTT	NP_000050.2:p.Lys3084AsnfsTer26
Ensemble	ENST00000713680.1:c.9096_9099delinsTT	ENST00000713680.1:p.Lys3032AsnfsTer26
	ENST00000713678.1:c.9252_9255delinsTT	ENST00000713678.1:p.Lys3084AsnfsTer26
	ENST00000700202.2:c.9201_9204delinsTT	ENST00000700202.2:p.Lys3067AsnfsTer26
	ENST00000380152.8:c.9252_9255delinsTT	ENST00000380152.8:p.Lys3084AsnfsTer26
	ENST00000544455.6:c.9252_9255delinsTT	ENST00000544455.6:p.Lys3084AsnfsTer26
	ENST00000530893.7:c.8883_8886delinsTT	ENST00000530893.7:p.Lys2961AsnfsTer26

Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics	Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance	Pathogenic
Review star
Show details

Links

BRCA2

Type	Database	ID	Link
Gene	MIM	600185	OMIM
	HGNC	1101	HGNC
	Ensembl	ENSG00000139618	Ensembl
	NCBI		NCBI
	Gene Cards		Gene Cards
	OncoKB		OncoKB

Type	Database	ID	Link
Variant	TogoVar
	COSMIC
	MONDO

Disease area statistics

[No Data.]

MGeND

[No Data.]

ClinVar

Clinical significance	Last evaluated	Review status	Condition	Origin	Links
Pathogenic	2016-09-08	reviewed by expert panel	Breast-ovarian cancer, familial, susceptibility to, 2	germline	Detail
Pathogenic	2023-07-28	criteria provided, single submitter	hereditary breast ovarian cancer syndrome	germline	Detail
Pathogenic	2022-11-30	criteria provided, multiple submitters, no conflicts	Hereditary cancer-predisposing syndrome	germline	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail
Pathogenic	2022-02-04	criteria provided, single submitter	Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,medulloblastoma,Pancreatic cancer, susceptibility to, 2,Wilms tumor 1,Malignant tumor of prostate,Familial cancer of breast,Fanconi anemia complementation group D1	unknown	Detail

CIViC

[No Data.]

DisGeNET

Score	Disease name	Description	Source	Pubmed	Links
0.240	Breast-ovarian cancer, familial, susceptibility to, 2	NA	CLINVAR		Detail
0.391	Hereditary Breast and Ovarian Cancer Syndrome	NA	CLINVAR		Detail

Annotation

Annotations

Descrption	Source	Links
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND Breast-ovarian cancer, familial, susceptibi...	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND Hereditary breast ovarian cancer syndrome	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND Hereditary cancer-predisposing syndrome	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.9252_9255delinsTT (p.Lys3084fs) AND multiple conditions	ClinVar	Detail
NA	DisGeNET	Detail
NA	DisGeNET	Detail

Overlapped Transcript Coordinates

Gene	Transcript ID	Exon Number	Chromosome	Start	Stop	Type	Amino Mutation	Transcript Position	Links

Overlapped Transcript

Gene	Transcript ID	Chromosome	Start	Stop	Links

Gene: -
dbSNP: rs276174918 dbSNP
Genome: hg19
Position: chr13:32,954,278-32,954,281
Variant Type: snv
Reference Allele: AACA
Alternative Allele: TT

Genome browser